Invuity to Present at Cantor Fitzgerald Global Healthcare Conference

SAN FRANCISCO, Sept. 13, 2017 (GLOBE NEWSWIRE) -- Invuity, Inc. (NASDAQ: IVTY), a leading medical technology company focused on minimal access surgery, announced today that company management is scheduled to present at the Cantor Fitzgerald Global Healthcare Conference on Tuesday, September 26, 2017 at 10:55 a.m. Eastern Time in New York City.

A live, listen-only webcast of the presentation may be accessed by visiting the Events & Presentations section of the Company's website at www.invuity.com under Investors & Media. A replay of the webcast will be available shortly after the conclusion of the presentation and will be archived on the Company's website for 30 days following the presentation.

About Invuity®Invuity, Inc. is a leading medical technology company focused on developing and marketing advanced surgical devices to improve the ability of physicians to perform minimal access surgery through smaller and hidden incisions. The company's patented Intelligent Photonics™ technology delivers enhanced visualization which facilitates surgical precision, efficiency and safety. In addition, the company utilizes comprehensive strategic marketing programs to create stronger institutional partnerships. Clinical applications include women’s health, encompassing breast cancer and breast reconstruction surgery, gynecology and thyroid surgery.  Additional applications include procedures for electrophysiology, spine, orthopedic, cardiothoracic, and general surgery. Invuity is headquartered in San Francisco, CA. For more information, visit www.invuity.com.

CONTACT:Company Contact:Jim MackanessChief Financial OfficerInvuity, Inc.415-655-2129

Investors:Mark KlausnerWestwicke Partners443-213-0501[email protected]

You May Also Be Interested In

• Glodon Launches QuantifAI in Malaysia at AEC Connect Day 2026, Advancing AI-Powered Quantity Takeoff
• Grant & Eisenhofer Files Class Action Lawsuit Against Intuit Inc., Extending Class Period of Previously Filed Action
• KARMAN LINE ACQUISITION CORP. Announces Pricing of $200 Million Initial Public Offering